2B70:XETRA:XETRA-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 6.013

Change

+0.09 (+1.50)%

Market Cap

USD 0.52B

Volume

0.17M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

ETFs Containing 2B70:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.36% 42% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.36% 42% F 44% F
Trailing 12 Months  
Capital Gain 7.84% 40% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.84% 40% F 44% F
Trailing 5 Years  
Capital Gain 44.51% 60% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.51% 59% D- 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.33% 60% D- 58% F
Dividend Return 6.33% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.42% 43% F 54% F
Risk Adjusted Return 43.91% 55% F 58% F
Market Capitalization 0.52B 68% D+ 60% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.